REG - Aseana Prop Ltd - Waiver in respect of a Covenant to a Bank Loan

Aseana PropertiesAnnouncement

17/05/2019 16:10

RNS Number : 4626Z
Aseana Properties Limited
17 May 2019
 


Aseana Properties Limited
("Aseana" or the "Company")
 
 Waiver in respect of Non-compliance of a Financial Covenant to a Bank Loan
 
Aseana Properties Limited (LSE: ASPL), a property developer in Malaysia and Vietnam listed on the Main Market of the London Stock Exchange, announces that one of its subsidiary undertakings has on 6 May 2019 received a waiver from the lenders in respect of the non-compliance of a financial covenant to a bank loan, as disclosed in the  Auditor's Report and Note 2.1 to the Company's Financial Statements for the year ended 31 December 2018.
 
 
For further information:
 



Aseana Properties Limited


Tel: +603 6411 6388




Chan Chee Kian


Email: cheekian.chan@ireka.com.my







 




N+1 Singer


Tel: 020 7496 3000




James Maxwell / James Moat (Corporate Finance)
Sam Greatrex (Sales)















Tavistock Communications


Tel: 020 7920 3150




Jeremy Carey / James Verstringhe


Email: jeremy.carey@tavistock.co.uk
















Notes to Editors:
 
London-listed Aseana Properties Limited (LSE: ASPL) is a property developer investing in Malaysia and Vietnam.
 
Ireka Development Management Sdn Bhd ("IDM") is the exclusive Development Manager for Aseana. It is a wholly-owned subsidiary of Ireka Corporation Berhad, a company listed on the Bursa Malaysia since 1993, which has over 52 years of experience in construction and property development. IDM is responsible for the day-to-day management of Aseana's property portfolio and the divestment of existing properties.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUBRVRKNAVAAR